An Open-label, Long-term Study of Telmisartan Plus Amlodipine Fixed-dose Combination

NCT00618774 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

259

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension

Interventions

DRUG: telmisartan40/amlodipine5
DRUG: telmisartan80/amlodipine5

Sponsor

Boehringer Ingelheim